BioNTech, which developed one of the world’s most commonly used COVID-19 vaccines along with Pfizer, is attempting to gain approval soon for vaccinating children between the ages of 5 and 11 across the world, top executives with the firm announced Friday.
“Already over the next few weeks we will file the results of our trial in 5- to 11-year-olds with regulators across the world and will request approval of the vaccine in this age group, also here in Europe,” Chief Medical Officer Oezlem Tuereci told German publication Der Spiegel…
Trending:
- Israel Introduces A New Bill To Outlaw Teaching The Gospel of Jesus Christ and Imprison Violators
- Large investors tried to redeem, and Blackstone said “sorry, no”. There is no buyer. This is 2008 again.
- China will officially join Iran to arm Russia, “if Kyiv does not accept the Chinese peace plan”
- The Great Financial Collapse of 2023. Comparison of Bear Stearns’ collapse in March 2008 and Credit Suisse in March 2023.
- OPRAH STANDS TO LOSE $590 MILLION AFTER COLLAPSE OF SVB
- Deadly Fungus Spreading Rapidly Through Hospitals
- Sperm has been almost entirely replaced by spike proteins
- Sending Depleted Uranium Munitions To Ukraine Is A War Crime Against The Ukrainian People
- Mexico begins to Confiscate and Seize American business in Mexico
- Literally 20+ media taking images of two people
Views: 34